NIH-funded research NIH-funded research

Digital health tool to monitor and manage CAR-T recovery symptoms

Official title: Improving patient outcomes through a digital health delivered intervention to monitor and manage symptoms after chimeric antigen receptor T-cell therapy

Funded at Mcc Health, INC · NIH-11405310 · Data updated 2026-11-12

A patient-facing digital program helps people who had CAR-T therapy track and manage common recovery symptoms to feel better and stay on top of their health.

More Digital Health research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMcc Health, INC
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$201,112
NIH project number1R41CA314618-01
Project IDNIH-11405310 on NIH RePORTER

Who could benefit from this research

Could help

Adults treated with CAR-T therapy for hematological diseases who are discharged and navigating early recovery (up to 90 days).

Less likely to help

Patients not using digital tools or without access to digital devices may not experience direct benefits.

What this research studies

This project will develop a user-friendly digital intervention (MCC-CAR-T) that patients use after CAR-T therapy to monitor symptoms, receive guidance, and build confidence in managing their recovery. It will test feasibility, acceptability, and impact on self-efficacy and quality of life during the first 90 days after discharge. The team will tailor symptom monitoring to common CAR-T–related issues like fatigue, pain, infections, and neurotoxic effects, with feedback to patients and caregivers. If successful, the program could become a practical tool to reduce symptom burden and potentially lower readmission risk. The study is conducted in people treated for hematologic diseases who are navigating outpatient recovery after CAR-T treatment.

Why it matters

Potential benefit: If the digital tool proves feasible and acceptable, patients could experience better symptom control, higher self-efficacy, and improved quality of life during CAR-T recovery.

How similar studies have gone: Previous symptom-monitoring interventions in other populations showed reduced symptom burden and improved QoL, but this is the first focused on CAR-T recovery.

Where this research is happening

  • Mcc Health, INC
    New York, United States
    Active

Researchers

  • Principal investigator: Landau, Daniella — Mcc Health, INC
  • Study coordinator: Landau, Daniella

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.